[What are the main novelties in the recent US and European guidelines for the management of hypertension?]
G Ital Cardiol (Rome)
.
2018 Nov;19(11):611-619.
doi: 10.1714/3012.30108.
[Article in Italian]
Authors
Paolo Verdecchia
1
,
Fabio Angeli
2
,
Claudio Cavallini
1
,
Giuseppe Ambrosio
2
,
Adolfo Aita
1
,
Dario Turturiello
2
,
Gianpaolo Reboldi
3
Affiliations
1
Fondazione Umbra Cuore e Ipertensione-ONLUS e S.C. Cardiologia, Ospedale S. Maria della Misericordia, Perugia.
2
S.C. Cardiologia e Fisiopatologia Cardiovascolare, Ospedale S. Maria della Misericordia, Perugia.
3
Dipartimento di Medicina, Università degli Studi, Perugia.
PMID:
30425390
DOI:
10.1714/3012.30108
No abstract available
Publication types
Editorial
MeSH terms
Antihypertensive Agents / administration & dosage*
Europe
Humans
Hypertension / diagnosis
Hypertension / therapy*
Practice Guidelines as Topic*
Risk Factors
United States
Substances
Antihypertensive Agents